Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


GLYC: First Patient Dosed In Trial Evaluating Uproleselan As Prophylactic Agent To Reduce Gastrointestinal Toxicities


RTTNews | May 26, 2021 09:52AM EDT

09:52 Wednesday, May 26, 2021 (RTTNews) - GLYC: First Patient Dosed In Trial Evaluating Uproleselan As Prophylactic Agent To Reduce Gastrointestinal Toxicities

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC